Hanza rapporterade ett kvartal över Analysguidens förväntan.
MoveByBike Europe AB ("MoveByBike" eller "Bolaget") meddelade den 5 november 2024 att partnerskapet ...
Q3 results in-line, cash burn of DKK 27m Small new design win (~1k units), reiterates target of 4-6 ...
Redeye comments on Climeon’s Q3 figures that posted a variety of deviations from our estimates.
Q-linea continues improving the pipeline of prospects of various stages, from entering tenders to cl...
Sales -2%, adj. EBIT +4m vs. FactSet consensus Better EBIT largely driven by improved cost control E...
Taaleri reported recurring revenues of EUR 9.7m (-6% y/y), 4% below our estimate, mostly explained b...
Q3 EBITDA of 15.2m, in line with ABGSCe of USD 15.3m Small downward revisions to guidance Q3 much as...
Redeye comments on Freemelt’s Q3 results, which were roughly in line with expectations in terms of s...
Redeye comments on the US CMS rate change for 2025.
Redeye provides an initial comment on the Q3 2024 report from Cheffelo, which came in below our esti...
Redeye states that the CoinShares Q3 2024 report was solid, with asset management fees above RRe, wh...
Redeye initiates coverage of Jumpgate, a gaming company focused on PC and Console.
Last year was a fairly weak one for Tallinna Sadam, but the tone has changed for 2024.
IRLAB’s Q324 results highlighted progress across its clinical pipeline.
Redeye comments on the proposed increased rate for Medicare and Medicaid for 2025 under the OPPS and...
Cyberattack impact on sales likely ~SEK 5-10m We cut '24e-'26e sales by 1% '25e-'26e EV/EBIT 21x-10x...
Redeye views today’s press release from Acarix as a positive development, confirming new reimburseme...
While the Q3’24 report did not contain any particular surprises in terms of financials, it did provi...
Redeye updates its estimates after reviewing Tessin's Q3 report, which came in below our expectation...